REARRANGEMENT OF INDOLINESULFONAMIDES TO SULFONES
1843
(20 mL) and was recrystallized (isopropyl alcohol) to give 5-chloro-1-[(2-o-nitro-
phenyl)sulfonyl]indoline (5.12 g, 83%) as white fine white crystals: mp
7
158–159ꢀC; IR (KBr pellet): 1544.61 cmꢃ1 (NO2 asym str.), 1377.78 cmꢃ1 (NO2
sym str.), 1364.01 cmꢃ1 (SO2 asym str.), 1174.07 cmꢃ1 (SO2 sym str.); 1H
(400 MHz, CDCl3): d 7.96 (d, J ¼ 8.6, 1H), 7.74 (t, J ¼ 8.2, 1H), 7.66 (m, J ¼ 8.2,
8.6, 2H), 7.39 (d, J ¼ 8.2, 1H), 7.16 (d, J ¼ 8.6, 1H) 7.15 (s, 1H), 4.10 (t, J ¼ 8.4,
2H), 3.08 (t, J ¼ 8.4, 2H); 13C NMR: (100 MHz, CDCl3) d 140.23, 134.63,
134.08, 132.11, 129.84, 128.18, 126.05, 124.74, 115.85, 77.76, 77.44, 77.12, 51.06,
28.30; MS m=z 338.
Preparation of 5-Methyl-1-[(4-methylphenyl)sulfonyl]indoline (8)
In a vial equipped with a magnetic stir bar, 5-methylindoline 2 (0.30 g,
2.25 mmol) was added along with base (K2CO3=H2O, 1 g=mL, 1 mL). Tosyl chloride
(0.24 g, 2.25 mmol) was dissolved in CH2Cl2 and pipetted into the vial. The reaction
was stirred at room temperature and was monitored by TLC (2:1 hexane=ethyl acet-
ate, product Rf ¼ 0.49). The product was extracted and washed with brine. The
organic phase was dried over magnesium sulfate and filtered, and the solvent was
removed in vacuo. The crude solid was purified by column chromatography
(hexane=ethyl acetate, silica gel, gradient 0–100%). The product, 5-methyl-1-
[(4-methylphenyl)sulfonyl]indoline 8 (0.40 g, 62% isolated yield)ꢃw1as a white powder:
mp 99–100.5ꢀC (lit.[4] 75–77ꢀC); IR: (thin film) 1352.44 cm
(SO2 asym str.),
1164.29 cmꢃ1 (SO2 sym str.); H (400 MHz, CDCl3): 7.66 (d, J ¼ 8.2, 2H), 7.48 (d,
J ¼ 8.1, 1H), 7.23 (d, J ¼ 8.2, 2H), 6.89 (d, J ¼ 8.1, 1H), 6.59 (s, 1H), 3.81 (t,
J ¼ 8.5, 2H), 2.50 (t, J ¼ 8.5, 2H), 2.32 (s, 3H), 2.24 (s, 3H); 13C NMR (100 MHz,
CDCl3): d 144.28, 140.04, 134.42, 133.86, 132.39, 129.99, 128.60, 127.75, 125.13,
115.40, 50.50, 28.29, 92.8, 21.27; MS m=z 287.
1
Preparation of 5-Methyl-1-[(2-nitrophenyl)sulfonyl]indoline (9)
5-Methyl indoline 3 (0.30 g, 2.3 mmol) was added with base (10% NaOH, 1 mL)
to a vial equipped with a magnetic stir bar. The 2-nitrobenzenesulfonyl chloride
(0.24 g, 2.3 mmol) was dissolved in CH2Cl2 (5 mL) and was pipetted into the vial.
The reaction was stirred at room temperature and monitored by TLC (2:1
hexane=ethyl acetate, product Rf ¼ 0.31). The product was extracted with ethyl acet-
ate and washed with brine. The organic phase was dried over magnesium sulfate.
The solvent was removed in vacuo. The crude solid was purified by column chroma-
tography (hexane=ethyl acetate, silica gel, gradient 0–100%). The product,
5-methyl-1-[(2-nitrophenyl)-sulfonyl]indoline 9 (0.42 g, 59% isolated yield) gave
white crystals: mp 142–143ꢀC; IR: (KBr Pellet) 1547.09 cmꢃ1 (NO2 asym str.),
1377.79 cmꢃ1 (NO2 sym str.), 1358.69 cmꢃ1 (SO2 asym str.), 1175.05 cmꢃ1 (SO2
1
sym str.); H (400 MHz, CDCl3): d 7.93 (d, J ¼ 8.6, 2H), 7.70 (t, J ¼ 8.2, 1H), 7.65
(m, J ¼ 8.6, 2H), 7.37 (d, J ¼ 8.5, 1H), 7.01 (d, J ¼ 7.9, 1H), 6.99 (s, 1H), 4.13 (t,
J ¼ 8.3, 2H), 3.03 (t, J ¼ 8.3, 2H), 2.31 (s, 3H); 13C NMR (101 MHz, CDCl3): d
139.11, 136.88, 134.49, 134.23, 131.89, 130.63, 128.66, 126.51, 124.51, 114.86,
77.75, 77.43, 77.11, 50.96, 28.46; MS m=z 318.